Market Outlook
The global Albendazole market size was valued at USD 163.7 million in 2022 and is forecast to a readjusted size of USD 271 million by 2029 with a CAGR of 7.5% during review period.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
This report is a detailed and comprehensive analysis for global Albendazole market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Albendazole market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Albendazole market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Albendazole market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Albendazole market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albendazole
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albendazole market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Segmentation By Type
Tablet
Capsule
Other
Segmentation By Application
Human
Veterinary
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Albendazole market in 2025?
The increasing demand for Albendazole as a deworming agent, especially in developing countries, strengthens the market. The growing awareness of parasitic infections and the continuous need for effective treatments drive demand. Additionally, the cost-effectiveness of Albendazole ensures its wide usage, especially in mass drug administration programs.
What are the weaknesses of the Albendazole market in 2025?
A major weakness is the potential side effects associated with prolonged use, such as liver toxicity, which could limit its use in certain populations. Also, the development of resistance to Albendazole in some parasitic strains is a concern, which may reduce its effectiveness over time. Limited access to healthcare infrastructure in some regions also affects the distribution and effectiveness of the drug.
What opportunities exist in the Albendazole market in 2025?
The growing focus on neglected tropical diseases (NTDs) offers significant opportunities for Albendazole, particularly in underdeveloped regions where parasitic infections are more prevalent. Partnerships with international health organizations and governments for large-scale deworming programs can open new markets. There is also potential for Albendazole to be combined with other therapies for broader therapeutic applications.
What threats could impact the Albendazole market in 2025?
The introduction of alternative, more effective anti-parasitic drugs could pose a threat to Albendazole's market share. Increased regulation and restrictions on its use due to safety concerns or environmental impact could also harm its availability. Additionally, the potential emergence of drug-resistant strains of parasites could reduce its long-term effectiveness.
Market PESTEL Analysis
What political factors could affect the Albendazole market in 2025?
Government policies on healthcare spending and drug distribution will heavily influence the Albendazole market. Increased political focus on controlling neglected tropical diseases (NTDs) can lead to more funding for Albendazole distribution. However, changes in drug regulation or restrictions on certain medications due to political reasons could impact market access.
How do economic factors impact the Albendazole market in 2025?
Albendazole is widely used in cost-effective public health initiatives, which makes its affordability a key economic factor. In developing countries, economic growth or downturns can influence funding for mass deworming programs. A rise in healthcare budgets and improved economic conditions can increase the availability and accessibility of Albendazole.
What social factors affect the Albendazole market in 2025?
The growing awareness of parasitic diseases and the importance of deworming programs will boost demand for Albendazole. Increased public health education and awareness campaigns in regions where parasitic infections are prevalent will likely drive the market. However, cultural beliefs or resistance to treatment in certain areas could hinder widespread adoption.
What technological factors impact the Albendazole market in 2025?
Advancements in drug formulation and delivery systems may improve the effectiveness and safety profile of Albendazole. New technologies for drug resistance monitoring could help ensure its continued efficacy. Additionally, innovations in global health infrastructure, such as digital health tracking for mass deworming programs, may facilitate wider distribution.
How do environmental factors influence the Albendazole market in 2025?
Environmental conditions, such as poor sanitation and contaminated water sources, contribute to the spread of parasitic infections, driving demand for Albendazole. Climate change could also alter the distribution of certain parasitic diseases, affecting Albendazole's market. Additionally, environmental concerns over pharmaceutical waste could prompt stricter regulations on drug disposal and use.
What legal factors affect the Albendazole market in 2025?
Intellectual property laws, patent expirations, and regulatory approval processes can impact the availability and price of Albendazole. Stricter regulations regarding drug safety, especially concerning long-term use and potential side effects, could influence market access. Furthermore, legal actions related to drug resistance and environmental concerns could result in new legislation or guidelines that affect Albendazole's marketability.
Market SIPOC Analysis
Who are the suppliers in the Albendazole market in 2025?
Suppliers include pharmaceutical manufacturers, raw material suppliers for the active pharmaceutical ingredients (APIs), and distributors that handle the bulk distribution of Albendazole. The supply chain also involves international health organizations and government bodies that procure and distribute the drug for mass deworming programs.
What are the inputs needed for the Albendazole market in 2025?
Inputs include raw materials for drug production (e.g., Albendazole API, excipients), manufacturing facilities, labor, research and development for improving drug efficacy and safety, as well as regulatory approvals from health authorities. Logistics and distribution networks for reaching underserved regions also play a critical role in the inputs.
What are the processes involved in the Albendazole market in 2025?
Processes include the manufacturing of Albendazole, quality control, and regulatory compliance to meet the standards of health authorities. Distribution to healthcare providers, NGOs, and government programs is a key part of the process, along with monitoring usage and gathering data for research. Additionally, global health campaigns and educational programs to raise awareness about parasitic infections are important.
Who are the customers of the Albendazole market in 2025?
Customers primarily include healthcare providers, government health departments, non-governmental organizations (NGOs), and international health organizations like the WHO, who purchase Albendazole for mass deworming campaigns. Private healthcare providers, pharmacies, and patients in regions affected by parasitic infections are also significant customers.
What are the outcomes expected from the Albendazole market in 2025?
The expected outcomes include the widespread reduction in parasitic infections, especially in developing countries, thanks to improved deworming programs. Better healthcare outcomes, improved public health infrastructure, and increased awareness of parasitic diseases are anticipated results. The market is also expected to grow in terms of accessibility and affordability for both individuals and healthcare systems.
Market Porter's Five Forces
What is the threat of new entrants in the Albendazole market in 2025?
The threat of new entrants is relatively low due to high barriers to entry, including stringent regulatory requirements, the need for substantial capital investment in manufacturing, and the complexities of global distribution networks. Established pharmaceutical companies with resources and regulatory experience dominate the market, making it difficult for new competitors to enter.
How strong is the bargaining power of suppliers in the Albendazole market in 2025?
The bargaining power of suppliers is moderate. While there are a few key suppliers of raw materials, such as Albendazole APIs, the market is not entirely dependent on a single supplier. However, changes in raw material prices or supply chain disruptions could influence costs for pharmaceutical manufacturers, making suppliers a notable factor in pricing.
What is the bargaining power of buyers in the Albendazole market in 2025?
The bargaining power of buyers is moderate to high, especially for large buyers like government health programs, international health organizations, and NGOs. These buyers often negotiate lower prices due to bulk purchasing and the importance of Albendazole in mass deworming initiatives. However, the lack of widely available alternatives for treating parasitic infections limits the overall bargaining power of smaller buyers.
What is the threat of substitute products in the Albendazole market in 2025?
The threat of substitutes is low. While there are alternative anti-parasitic drugs available, Albendazole remains one of the most cost-effective and widely used options for treating a range of parasitic infections. The lack of a broadly available, equally effective, and affordable substitute helps maintain Albendazole's dominance in the market.
How intense is the competitive rivalry in the Albendazole market in 2025?
Competitive rivalry in the Albendazole market is moderate. While a few large pharmaceutical companies dominate the market, competition primarily comes from the limited number of generics and alternative treatments. The key drivers of competition include pricing, regulatory approval, and the ability to distribute the drug widely to underserved populations. However, due to Albendazole's essential role in public health initiatives, competition is often more focused on supply and access rather than direct product differentiation.
Market Upstream Analysis
What are the key upstream factors impacting the Albendazole market in 2025?
Key upstream factors include the availability and cost of raw materials required for the production of Albendazole, particularly the active pharmaceutical ingredient (API). Regulatory requirements for manufacturing and the approval process for raw materials play a significant role in shaping production timelines and costs. Additionally, the quality control of these inputs is crucial for ensuring the efficacy and safety of the final product.
How do suppliers of raw materials influence the Albendazole market in 2025?
Suppliers of raw materials hold a moderate to high influence over the Albendazole market due to their control over the cost and availability of active ingredients. Disruptions in the supply of these materials, whether due to geopolitical factors, environmental issues, or price fluctuations, can directly impact manufacturing costs and production capabilities, affecting market prices and availability.
What role does research and development play in the upstream dynamics of the Albendazole market in 2025?
Research and development (R&D) is critical for the continued improvement of Albendazole’s formulation and its efficacy against emerging parasitic strains. Upstream R&D efforts can lead to more cost-effective manufacturing processes, as well as the development of combination therapies, which could influence demand for Albendazole. Investment in R&D can also drive innovation in overcoming resistance issues, ensuring Albendazole remains a first-line treatment option.
How does the regulatory environment affect the upstream factors in the Albendazole market in 2025?
The regulatory environment significantly impacts the upstream factors of the Albendazole market. Stringent guidelines on drug production, quality control, and approval processes can delay production and increase costs. Compliance with global and local regulations, particularly in developing countries, is essential to ensuring widespread access to Albendazole. Regulatory changes or new safety standards could also alter the supply chain dynamics and manufacturing processes.
What impact do manufacturing capabilities and scale have on the Albendazole market in 2025?
Manufacturing capabilities and scale have a considerable impact on the Albendazole market, as larger-scale production can lower per-unit costs, improving affordability and access. Manufacturers with extensive production capacity can meet the high demand from global health initiatives, particularly in low-income regions. However, limitations in manufacturing facilities or supply chain disruptions could hinder the production and availability of Albendazole, especially in remote areas.
Market Midstream Analysis
What are the key midstream factors affecting the Albendazole market in 2025?
Key midstream factors include the distribution networks, logistics, and partnerships with healthcare providers and governments. Efficient distribution channels ensure that Albendazole reaches target populations, especially in remote or underserved regions. Strong collaborations with global health organizations and local healthcare authorities also help streamline the delivery process.
How do distribution networks impact the Albendazole market in 2025?
Distribution networks play a crucial role in ensuring that Albendazole is accessible, especially in regions where parasitic infections are prevalent. Effective supply chain management, including cold chain logistics, is necessary to maintain the drug’s efficacy during transportation. Delays or inefficiencies in distribution could lead to shortages and hamper mass deworming programs, limiting market reach.
What role do partnerships and collaborations play in the Albendazole market in 2025?
Partnerships with international organizations such as the World Health Organization (WHO), NGOs, and government bodies are vital for scaling up Albendazole distribution. These collaborations help with bulk purchasing, funding, and implementing mass drug administration campaigns. Such alliances also enable access to underdeveloped regions where Albendazole is most needed.
How does the regulatory environment influence midstream factors in the Albendazole market in 2025?
The regulatory environment influences midstream factors by determining the logistics and approval processes for drug distribution. Regulatory frameworks that prioritize public health can facilitate faster approval for mass distribution and allow for smoother entry into local markets. However, stringent regulations could delay or complicate the logistics of getting Albendazole to the intended populations.
What is the role of pricing strategies in the midstream of the Albendazole market in 2025?
Pricing strategies play a significant role in the midstream by influencing both affordability and accessibility. Competitive pricing, especially for bulk purchasing by governments and international organizations, ensures widespread distribution. The affordability of Albendazole in mass deworming programs is essential for its continued use in global health initiatives, ensuring that even low-income populations have access to the drug.
Market Downstream Analysis
What are the key downstream factors impacting the Albendazole market in 2025?
Key downstream factors include healthcare providers' adoption of Albendazole, patient accessibility, and demand from government programs focused on public health. Effective implementation of deworming campaigns and the overall healthcare infrastructure in target regions will significantly influence the drug's uptake. Additionally, patient education about the importance of treating parasitic infections plays a crucial role in ensuring sustained demand.
How do healthcare providers influence the Albendazole market in 2025?
Healthcare providers are essential in the downstream market as they are the ones prescribing Albendazole for treating parasitic infections. Their awareness of the drug's effectiveness and safety profile, along with recommendations for mass deworming programs, drives its use. Increased education on the benefits of Albendazole in combating neglected tropical diseases can further push its demand.
What role does government policy play in the downstream of the Albendazole market in 2025?
Government policy is a major driver in the downstream market, particularly in low-income regions where Albendazole is included in national health programs for parasitic disease control. Supportive policies that fund or subsidize drug distribution help ensure widespread access, while public health initiatives often focus on mass deworming campaigns. These policies can significantly increase demand for Albendazole.
How do patient accessibility and affordability affect the Albendazole market in 2025?
Patient accessibility and affordability are critical factors in the downstream market. Albendazole’s low cost and availability through public health programs make it accessible to a wide range of populations, particularly in developing countries. However, challenges like poor infrastructure, inadequate healthcare facilities, and transportation issues can still limit its reach to the most affected regions.
What impact does awareness and education have on the downstream factors in the Albendazole market in 2025?
Awareness and education are fundamental to driving the downstream demand for Albendazole. Public health campaigns that educate individuals and communities about parasitic infections and the importance of deworming can increase patient demand. Informed patients are more likely to seek treatment and adhere to prescribed courses, helping to maintain the drug’s effectiveness and market demand.
Chapter 1, to describe Albendazole product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albendazole, with price, sales, revenue and global market share of Albendazole from 2018 to 2023.
Chapter 3, the Albendazole competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albendazole breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Albendazole market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albendazole.
Chapter 14 and 15, to describe Albendazole sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Albendazole
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Albendazole Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Albendazole Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Human
1.4.3 Veterinary
1.5 Global Albendazole Market Size & Forecast
1.5.1 Global Albendazole Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Albendazole Sales Quantity (2018-2029)
1.5.3 Global Albendazole Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Albendazole Product and Services
2.1.4 GlaxoSmithKline Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Huazhong Pharmaceutical
2.2.1 Huazhong Pharmaceutical Details
2.2.2 Huazhong Pharmaceutical Major Business
2.2.3 Huazhong Pharmaceutical Albendazole Product and Services
2.2.4 Huazhong Pharmaceutical Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Huazhong Pharmaceutical Recent Developments/Updates
2.3 Jiangsu Qihui
2.3.1 Jiangsu Qihui Details
2.3.2 Jiangsu Qihui Major Business
2.3.3 Jiangsu Qihui Albendazole Product and Services
2.3.4 Jiangsu Qihui Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Jiangsu Qihui Recent Developments/Updates
2.4 Sequent Scientific
2.4.1 Sequent Scientific Details
2.4.2 Sequent Scientific Major Business
2.4.3 Sequent Scientific Albendazole Product and Services
2.4.4 Sequent Scientific Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sequent Scientific Recent Developments/Updates
2.5 K.A. Malle Pharmaceuticals
2.5.1 K.A. Malle Pharmaceuticals Details
2.5.2 K.A. Malle Pharmaceuticals Major Business
2.5.3 K.A. Malle Pharmaceuticals Albendazole Product and Services
2.5.4 K.A. Malle Pharmaceuticals Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 K.A. Malle Pharmaceuticals Recent Developments/Updates
2.6 Lasa Supergenerics Limited
2.6.1 Lasa Supergenerics Limited Details
2.6.2 Lasa Supergenerics Limited Major Business
2.6.3 Lasa Supergenerics Limited Albendazole Product and Services
2.6.4 Lasa Supergenerics Limited Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lasa Supergenerics Limited Recent Developments/Updates
2.7 Zhongjia Pharmaceutical
2.7.1 Zhongjia Pharmaceutical Details
2.7.2 Zhongjia Pharmaceutical Major Business
2.7.3 Zhongjia Pharmaceutical Albendazole Product and Services
2.7.4 Zhongjia Pharmaceutical Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zhongjia Pharmaceutical Recent Developments/Updates
2.8 Fredun Pharmaceuticals Ltd
2.8.1 Fredun Pharmaceuticals Ltd Details
2.8.2 Fredun Pharmaceuticals Ltd Major Business
2.8.3 Fredun Pharmaceuticals Ltd Albendazole Product and Services
2.8.4 Fredun Pharmaceuticals Ltd Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates
2.9 Supharma Chem
2.9.1 Supharma Chem Details
2.9.2 Supharma Chem Major Business
2.9.3 Supharma Chem Albendazole Product and Services
2.9.4 Supharma Chem Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Supharma Chem Recent Developments/Updates
2.10 Salius Pharma
2.10.1 Salius Pharma Details
2.10.2 Salius Pharma Major Business
2.10.3 Salius Pharma Albendazole Product and Services
2.10.4 Salius Pharma Albendazole Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Salius Pharma Recent Developments/Updates
3 Competitive Environment: Albendazole by Manufacturer
3.1 Global Albendazole Sales Quantity by Manufacturer (2018-2023)
3.2 Global Albendazole Revenue by Manufacturer (2018-2023)
3.3 Global Albendazole Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Albendazole by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Albendazole Manufacturer Market Share in 2022
3.4.2 Top 6 Albendazole Manufacturer Market Share in 2022
3.5 Albendazole Market: Overall Company Footprint Analysis
3.5.1 Albendazole Market: Region Footprint
3.5.2 Albendazole Market: Company Product Type Footprint
3.5.3 Albendazole Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Albendazole Market Size by Region
4.1.1 Global Albendazole Sales Quantity by Region (2018-2029)
4.1.2 Global Albendazole Consumption Value by Region (2018-2029)
4.1.3 Global Albendazole Average Price by Region (2018-2029)
4.2 North America Albendazole Consumption Value (2018-2029)
4.3 Europe Albendazole Consumption Value (2018-2029)
4.4 Asia-Pacific Albendazole Consumption Value (2018-2029)
4.5 South America Albendazole Consumption Value (2018-2029)
4.6 Middle East and Africa Albendazole Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Albendazole Sales Quantity by Type (2018-2029)
5.2 Global Albendazole Consumption Value by Type (2018-2029)
5.3 Global Albendazole Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Albendazole Sales Quantity by Application (2018-2029)
6.2 Global Albendazole Consumption Value by Application (2018-2029)
6.3 Global Albendazole Average Price by Application (2018-2029)
7 North America
7.1 North America Albendazole Sales Quantity by Type (2018-2029)
7.2 North America Albendazole Sales Quantity by Application (2018-2029)
7.3 North America Albendazole Market Size by Country
7.3.1 North America Albendazole Sales Quantity by Country (2018-2029)
7.3.2 North America Albendazole Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Albendazole Sales Quantity by Type (2018-2029)
8.2 Europe Albendazole Sales Quantity by Application (2018-2029)
8.3 Europe Albendazole Market Size by Country
8.3.1 Europe Albendazole Sales Quantity by Country (2018-2029)
8.3.2 Europe Albendazole Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Albendazole Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Albendazole Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Albendazole Market Size by Region
9.3.1 Asia-Pacific Albendazole Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Albendazole Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Albendazole Sales Quantity by Type (2018-2029)
10.2 South America Albendazole Sales Quantity by Application (2018-2029)
10.3 South America Albendazole Market Size by Country
10.3.1 South America Albendazole Sales Quantity by Country (2018-2029)
10.3.2 South America Albendazole Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Albendazole Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Albendazole Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Albendazole Market Size by Country
11.3.1 Middle East & Africa Albendazole Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Albendazole Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Albendazole Market Drivers
12.2 Albendazole Market Restraints
12.3 Albendazole Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Albendazole and Key Manufacturers
13.2 Manufacturing Costs Percentage of Albendazole
13.3 Albendazole Production Process
13.4 Albendazole Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Albendazole Typical Distributors
14.3 Albendazole Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Albendazole Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Albendazole Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Albendazole Product and Services
Table 6. GlaxoSmithKline Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Huazhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Huazhong Pharmaceutical Major Business
Table 10. Huazhong Pharmaceutical Albendazole Product and Services
Table 11. Huazhong Pharmaceutical Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Huazhong Pharmaceutical Recent Developments/Updates
Table 13. Jiangsu Qihui Basic Information, Manufacturing Base and Competitors
Table 14. Jiangsu Qihui Major Business
Table 15. Jiangsu Qihui Albendazole Product and Services
Table 16. Jiangsu Qihui Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Jiangsu Qihui Recent Developments/Updates
Table 18. Sequent Scientific Basic Information, Manufacturing Base and Competitors
Table 19. Sequent Scientific Major Business
Table 20. Sequent Scientific Albendazole Product and Services
Table 21. Sequent Scientific Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sequent Scientific Recent Developments/Updates
Table 23. K.A. Malle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. K.A. Malle Pharmaceuticals Major Business
Table 25. K.A. Malle Pharmaceuticals Albendazole Product and Services
Table 26. K.A. Malle Pharmaceuticals Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. K.A. Malle Pharmaceuticals Recent Developments/Updates
Table 28. Lasa Supergenerics Limited Basic Information, Manufacturing Base and Competitors
Table 29. Lasa Supergenerics Limited Major Business
Table 30. Lasa Supergenerics Limited Albendazole Product and Services
Table 31. Lasa Supergenerics Limited Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lasa Supergenerics Limited Recent Developments/Updates
Table 33. Zhongjia Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Zhongjia Pharmaceutical Major Business
Table 35. Zhongjia Pharmaceutical Albendazole Product and Services
Table 36. Zhongjia Pharmaceutical Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zhongjia Pharmaceutical Recent Developments/Updates
Table 38. Fredun Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Fredun Pharmaceuticals Ltd Major Business
Table 40. Fredun Pharmaceuticals Ltd Albendazole Product and Services
Table 41. Fredun Pharmaceuticals Ltd Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Fredun Pharmaceuticals Ltd Recent Developments/Updates
Table 43. Supharma Chem Basic Information, Manufacturing Base and Competitors
Table 44. Supharma Chem Major Business
Table 45. Supharma Chem Albendazole Product and Services
Table 46. Supharma Chem Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Supharma Chem Recent Developments/Updates
Table 48. Salius Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Salius Pharma Major Business
Table 50. Salius Pharma Albendazole Product and Services
Table 51. Salius Pharma Albendazole Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Salius Pharma Recent Developments/Updates
Table 53. Global Albendazole Sales Quantity by Manufacturer (2018-2023) & (K MT)
Table 54. Global Albendazole Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Albendazole Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 56. Market Position of Manufacturers in Albendazole, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Albendazole Production Site of Key Manufacturer
Table 58. Albendazole Market: Company Product Type Footprint
Table 59. Albendazole Market: Company Product Application Footprint
Table 60. Albendazole New Market Entrants and Barriers to Market Entry
Table 61. Albendazole Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Albendazole Sales Quantity by Region (2018-2023) & (K MT)
Table 63. Global Albendazole Sales Quantity by Region (2024-2029) & (K MT)
Table 64. Global Albendazole Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Albendazole Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Albendazole Average Price by Region (2018-2023) & (USD/MT)
Table 67. Global Albendazole Average Price by Region (2024-2029) & (USD/MT)
Table 68. Global Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 69. Global Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 70. Global Albendazole Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Albendazole Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Albendazole Average Price by Type (2018-2023) & (USD/MT)
Table 73. Global Albendazole Average Price by Type (2024-2029) & (USD/MT)
Table 74. Global Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 75. Global Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 76. Global Albendazole Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Albendazole Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Albendazole Average Price by Application (2018-2023) & (USD/MT)
Table 79. Global Albendazole Average Price by Application (2024-2029) & (USD/MT)
Table 80. North America Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 81. North America Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 82. North America Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 83. North America Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 84. North America Albendazole Sales Quantity by Country (2018-2023) & (K MT)
Table 85. North America Albendazole Sales Quantity by Country (2024-2029) & (K MT)
Table 86. North America Albendazole Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Albendazole Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 89. Europe Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 90. Europe Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 91. Europe Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 92. Europe Albendazole Sales Quantity by Country (2018-2023) & (K MT)
Table 93. Europe Albendazole Sales Quantity by Country (2024-2029) & (K MT)
Table 94. Europe Albendazole Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Albendazole Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 97. Asia-Pacific Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 98. Asia-Pacific Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 99. Asia-Pacific Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 100. Asia-Pacific Albendazole Sales Quantity by Region (2018-2023) & (K MT)
Table 101. Asia-Pacific Albendazole Sales Quantity by Region (2024-2029) & (K MT)
Table 102. Asia-Pacific Albendazole Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Albendazole Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 105. South America Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 106. South America Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 107. South America Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 108. South America Albendazole Sales Quantity by Country (2018-2023) & (K MT)
Table 109. South America Albendazole Sales Quantity by Country (2024-2029) & (K MT)
Table 110. South America Albendazole Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Albendazole Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Albendazole Sales Quantity by Type (2018-2023) & (K MT)
Table 113. Middle East & Africa Albendazole Sales Quantity by Type (2024-2029) & (K MT)
Table 114. Middle East & Africa Albendazole Sales Quantity by Application (2018-2023) & (K MT)
Table 115. Middle East & Africa Albendazole Sales Quantity by Application (2024-2029) & (K MT)
Table 116. Middle East & Africa Albendazole Sales Quantity by Region (2018-2023) & (K MT)
Table 117. Middle East & Africa Albendazole Sales Quantity by Region (2024-2029) & (K MT)
Table 118. Middle East & Africa Albendazole Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Albendazole Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Albendazole Raw Material
Table 121. Key Manufacturers of Albendazole Raw Materials
Table 122. Albendazole Typical Distributors
Table 123. Albendazole Typical Customers
List of Figures
Figure 1. Albendazole Picture
Figure 2. Global Albendazole Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Albendazole Consumption Value Market Share by Type in 2022
Figure 4. Tablet Examples
Figure 5. Capsule Examples
Figure 6. Other Examples
Figure 7. Global Albendazole Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Albendazole Consumption Value Market Share by Application in 2022
Figure 9. Human Examples
Figure 10. Veterinary Examples
Figure 11. Global Albendazole Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Albendazole Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Albendazole Sales Quantity (2018-2029) & (K MT)
Figure 14. Global Albendazole Average Price (2018-2029) & (USD/MT)
Figure 15. Global Albendazole Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Albendazole Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Albendazole by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Albendazole Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Albendazole Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Albendazole Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Albendazole Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Albendazole Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Albendazole Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Albendazole Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Albendazole Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Albendazole Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Albendazole Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Albendazole Average Price by Type (2018-2029) & (USD/MT)
Figure 30. Global Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Albendazole Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Albendazole Average Price by Application (2018-2029) & (USD/MT)
Figure 33. North America Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Albendazole Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Albendazole Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Albendazole Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Albendazole Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Albendazole Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Albendazole Consumption Value Market Share by Region (2018-2029)
Figure 53. China Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Albendazole Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Albendazole Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Albendazole Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Albendazole Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Albendazole Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Albendazole Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Albendazole Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Albendazole Market Drivers
Figure 74. Albendazole Market Restraints
Figure 75. Albendazole Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Albendazole in 2022
Figure 78. Manufacturing Process Analysis of Albendazole
Figure 79. Albendazole Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
